Dr Peter Rogan
President
Cytognomix Inc. and
University of Western Ontario
DSB5012
London
Canada
Name/email consistency: high
- Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations. Rogan, P.K., Svojanovsky, S., Leeder, J.S. Pharmacogenetics (2003)
- Sequence-based design of single-copy genomic DNA probes for fluorescence in situ hybridization. Rogan, P.K., Cazcarro, P.M., Knoll, J.H. Genome Res. (2001)